Software Healthcare Sector

Annexon

Market Cap: US$997.2m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

Odyssey Therapeutics

Market Cap: US$992.9m

A clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases.

Janux Therapeutics

Market Cap: US$978.2m

A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms technology to treat patients with cancer.

Solid Biosciences

Market Cap: US$973.6m

Develops therapies for neuromuscular and cardiac diseases in the United States.

Kura Oncology

Market Cap: US$966.1m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Geron

Market Cap: US$944.4m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Pacira BioSciences

Market Cap: US$924.0m

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Arbutus Biopharma

Market Cap: US$923.9m

A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.

Olema Pharmaceuticals

Market Cap: US$919.6m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

Hyperliquid Strategies

Market Cap: US$918.1m

Operates as a digital asset treasury company focused on the blockchain and cryptocurrency sector.

Collegium Pharmaceutical

Market Cap: US$916.4m

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Castle Biosciences

Market Cap: US$904.9m

A molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), atopic dermatitis (AD), and uveal melanoma.

Candel Therapeutics

Market Cap: US$902.9m

A clinical stage biopharmaceutical company, develops immunotherapies for cancer patients.

Design Therapeutics

Market Cap: US$900.5m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

CeriBell

Market Cap: US$892.3m

Operates as a medical technology company in the United States.

Theravance Biopharma

Market Cap: US$878.5m

A biopharmaceutical company, develops and commercializes medicines in the United States.

InMode

Market Cap: US$873.7m

Designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.

Talkspace

Market Cap: US$870.6m

Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.

Anteris Technologies Global

Market Cap: US$870.3m

A structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.

Aclaris Therapeutics

Market Cap: US$862.6m

A clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States.

Amphastar Pharmaceuticals

Market Cap: US$858.4m

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

SI-BONE

Market Cap: US$849.3m

A medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally.

HealthStream

Market Cap: US$846.2m

Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.

Climb Bio

Market Cap: US$846.0m

A clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases.

SpyGlass Pharma

Market Cap: US$841.9m

Operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.

Silence Therapeutics

Market Cap: US$841.1m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Attovia Therapeutics

Market Cap: US$825.3m

A clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States.

Advanced Medical Solutions Group

Market Cap: UK£609.2m

Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, France, Europe, the United States, and internationally.

Obsidian Therapeutics

Market Cap: US$819.7m

Operates as a clinical-stage biotechnology company developing engineered cell and gene therapies.

WELL Health Technologies

Market Cap: CA$1.1b

Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.

Beta Bionics

Market Cap: US$813.4m

A commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes.

Oxford Biomedica

Market Cap: UK£589.5m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Rigel Pharmaceuticals

Market Cap: US$795.4m

A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.

Aura Biosciences

Market Cap: US$793.3m

A clinical-stage biotechnology company, develops precision therapies to treat solid tumors.

Oculis Holding

Market Cap: US$791.4m

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally.

Immix Biopharma

Market Cap: US$781.2m

A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.